• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

垂体 1 谱系和 SF-1 谱系的多激素垂体瘤,伴有同步碰撞促皮质激素瘤:一种可能的干细胞现象。

Plurihormonal Pituitary Tumor of Pit-1 and SF-1 Lineages, with Synchronous Collision Corticotroph Tumor: a Possible Stem Cell Phenomenon.

机构信息

Institute of Endocrinology, Metabolism and Hypertension, Tel Aviv Sourasky Medical Center, 6 Weizmann Street, 64239, Tel Aviv, Israel.

Sackler Faculty of Medicine, Tel Aviv University, Tel Aviv, Israel.

出版信息

Endocr Pathol. 2019 Mar;30(1):74-80. doi: 10.1007/s12022-018-9562-3.

DOI:10.1007/s12022-018-9562-3
PMID:30610567
Abstract

Thyrotropin (TSH)-secreting pituitary tumors are the rarest functioning pituitary tumors. Nonetheless, they are not infrequently plurihormonal, as they may express/secrete hormones made by other pituitary cells derived from the Pit-1 lineage such as growth hormone (GH), prolactin (PRL), and α-subunit (αSU). However, adrenocorticotropin (ACTH) or gonadotropin secretion by such a tumor is exceptional. Although double pituitary tumors are rare, they often combine ACTH and GH secretion. A 41-year-old presented almost 2 years after delivering her 10th child; she had thyrotoxicosis (goiter and palpitations) masquerading as autoimmune postpartum thyroiditis. She was still breastfeeding and amenorrheic. She proved to have TSH, GH, PRL, and ACTH hypersecretion. Imaging revealed an invasive pituitary macrotumor. She had stigmata neither of Cushing's disease nor of acromegaly. Prior to surgery, hormonal control was achieved for close to 1 year by combined octreotide and cabergoline treatment with significant shrinking of the tumor. Following surgery, pathology revealed a collision tumor; the dominant lesion was positive for GH, βTSH, βFSH, and αSU and expressed both Pit-1 and SF-1.The smaller lesion was a corticotroph tumor. We report an unusual plurihormonal tumor co-expressing Pit-1 and SF-1 along with hormones made by cells of both lineages. Its simultaneous occurrence adjacent to a corticotroph tumor raises questions regarding the pathogenesis of these tumors. We propose the possibility of a stem cell tumor with multiple lineage differentiation. We hypothesize that pregnancy might have played a permissive role in tumorigenesis.

摘要

促甲状腺激素(TSH)分泌性垂体肿瘤是最罕见的功能性垂体肿瘤。尽管如此,它们并非不常见于多激素分泌,因为它们可能表达/分泌由 Pit-1 谱系衍生的其他垂体细胞产生的激素,如生长激素(GH)、催乳素(PRL)和α亚单位(αSU)。然而,这种肿瘤的促肾上腺皮质激素(ACTH)或促性腺激素分泌是异常的。虽然双垂体肿瘤很少见,但它们通常结合 ACTH 和 GH 分泌。一名 41 岁的女性在生下第十个孩子后近 2 年出现症状;她患有甲状腺毒症(甲状腺肿大和心悸),伪装为自身免疫性产后甲状腺炎。她仍在哺乳且闭经。她被证实存在 TSH、GH、PRL 和 ACTH 分泌过多。影像学显示侵袭性垂体大肿瘤。她既没有库欣病的特征,也没有肢端肥大症的特征。在手术前,通过联合奥曲肽和卡麦角林治疗近 1 年,实现了激素控制,肿瘤显著缩小。手术后,病理显示为碰撞性肿瘤;优势病变对 GH、βTSH、βFSH 和 αSU 呈阳性,表达 Pit-1 和 SF-1。较小的病变是促皮质激素肿瘤。我们报告了一种不常见的多激素肿瘤,同时表达 Pit-1 和 SF-1 以及两种谱系细胞产生的激素。它与促皮质激素肿瘤相邻同时发生,引发了对这些肿瘤发病机制的疑问。我们提出了一种具有多谱系分化的干细胞肿瘤的可能性。我们假设妊娠可能在肿瘤发生中起了许可作用。

相似文献

1
Plurihormonal Pituitary Tumor of Pit-1 and SF-1 Lineages, with Synchronous Collision Corticotroph Tumor: a Possible Stem Cell Phenomenon.垂体 1 谱系和 SF-1 谱系的多激素垂体瘤,伴有同步碰撞促皮质激素瘤:一种可能的干细胞现象。
Endocr Pathol. 2019 Mar;30(1):74-80. doi: 10.1007/s12022-018-9562-3.
2
Induction of GH, PRL, and TSH beta mRNA by transfection of Pit-1 in a human pituitary adenoma-derived cell line.通过在人垂体腺瘤衍生细胞系中转染Pit-1诱导生长激素、催乳素和促甲状腺激素β mRNA的表达。
Cell Tissue Res. 2005 Nov;322(2):269-77. doi: 10.1007/s00441-005-0033-z. Epub 2005 Nov 3.
3
A case of pituitary somatotroph adenoma with concomitant secretion of growth hormone, prolactin, and adrenocorticotropic hormone--an adenoma derived from primordial stem cell, studied by immunohistochemistry, in situ hybridization, and cell culture.一例同时分泌生长激素、催乳素和促肾上腺皮质激素的垂体生长激素腺瘤——通过免疫组织化学、原位杂交和细胞培养研究的源自原始干细胞的腺瘤
Acta Neurochir (Wien). 1996;138(8):1002-7. doi: 10.1007/BF01411291.
4
Pit-1 gene expression in human pituitary adenomas using the reverse transcription polymerase chain reaction method.采用逆转录聚合酶链反应法检测人垂体腺瘤中Pit-1基因的表达。
Clin Endocrinol (Oxf). 1996 Sep;45(3):263-72. doi: 10.1046/j.1365-2265.1996.00812.x.
5
Multihormonal pituitary adenoma concomitant with Pit-1 and Tpit lineage cells causing acromegaly associated with subclinical Cushing's disease: a case report.多激素垂体腺瘤伴 Pit-1 和 Tpit 谱系细胞导致肢端肥大症伴亚临床库欣病:病例报告。
BMC Endocr Disord. 2017 Sep 2;17(1):54. doi: 10.1186/s12902-017-0203-5.
6
Free alpha-subunit and intact TSH secretion in vitro are closely associated in human somatotroph adenomas.在人类生长激素腺瘤中,体外游离α亚基和完整促甲状腺激素分泌密切相关。
Eur J Endocrinol. 1998 Oct;139(4):378-86. doi: 10.1530/eje.0.1390378.
7
Digital analysis of hormonal immunostaining in pituitary adenomas classified according to WHO 2017 criteria and correlation with preoperative laboratory findings.根据世界卫生组织 2017 年标准分类的垂体腺瘤中激素免疫染色的数字分析及其与术前实验室检查结果的相关性。
Neurosurg Focus. 2020 Jun;48(6):E12. doi: 10.3171/2020.3.FOCUS2039.
8
Epidemiology and biomarker profile of pituitary adenohypophysial tumors.垂体腺垂体肿瘤的流行病学和生物标志物特征。
Mod Pathol. 2018 Jun;31(6):900-909. doi: 10.1038/s41379-018-0016-8. Epub 2018 Feb 12.
9
Pleiomorphism plurihormonal Pit-1-positive macroadenoma with central hyperthyroidism: a rare case report and literature review.Pit-1 阳性多激素分泌垂体大腺瘤伴中枢性甲亢:罕见病例报告及文献复习。
BMC Endocr Disord. 2022 Dec 21;22(1):325. doi: 10.1186/s12902-022-01220-2.
10
Double pituitary adenomas: six surgical cases.双垂体腺瘤:6例手术病例
Pituitary. 1999 May;1(3-4):243-50. doi: 10.1023/a:1009994123582.

引用本文的文献

1
PIT-1/SF-1-positive pituitary tumors in patients with acromegaly: transcriptomic perspective.肢端肥大症患者中PIT-1/SF-1阳性垂体瘤:转录组学视角
Acta Neuropathol Commun. 2025 Aug 14;13(1):174. doi: 10.1186/s40478-025-02091-z.
2
Double PitNETs: A Case Report and Literature Review.双重垂体神经内分泌肿瘤:病例报告及文献综述
Cancers (Basel). 2025 Feb 17;17(4):675. doi: 10.3390/cancers17040675.
3
High level of aneuploidy and recurrent loss of chromosome 11 as relevant features of somatotroph pituitary tumors.高倍体和 11 号染色体的反复缺失是生长激素细胞垂体肿瘤的重要特征。

本文引用的文献

1
GATA3 immunoreactivity expands the transcription factor profile of pituitary neuroendocrine tumors.GATA3 免疫反应扩大了垂体神经内分泌肿瘤的转录因子谱。
Mod Pathol. 2019 Apr;32(4):484-489. doi: 10.1038/s41379-018-0167-7. Epub 2018 Nov 2.
2
Synchronous Multiple Pituitary Neuroendocrine Tumors of Different Cell Lineages.同步发生的不同细胞谱系的垂体神经内分泌肿瘤。
Endocr Pathol. 2018 Dec;29(4):332-338. doi: 10.1007/s12022-018-9545-4.
3
TSH-STAINING PITUITARY ADENOMAS: RARE, SILENT, AND PLURIHOROMONAL.促甲状腺激素染色垂体腺瘤:罕见、无声、多激素分泌。
J Transl Med. 2024 Nov 4;22(1):994. doi: 10.1186/s12967-024-05736-0.
4
Co-expression of multiple transcription factors is associated with clinical features and endocrine prognosis in growth hormone-secreting pituitary adenomas.多种转录因子的共表达与生长激素分泌型垂体腺瘤的临床特征及内分泌预后相关。
Endocrine. 2025 Feb;87(2):788-799. doi: 10.1007/s12020-024-04082-x. Epub 2024 Oct 25.
5
Practical approaches to diagnosing PitNETs/adenomas based on cell lineage.基于细胞谱系诊断垂体神经内分泌肿瘤/腺瘤的实用方法。
Brain Pathol. 2025 Jan;35(1):e13298. doi: 10.1111/bpa.13298. Epub 2024 Aug 25.
6
A Non-Secreting Pituitary Adenoma That Changed to a Prolactinoma.一例转变为催乳素瘤的无分泌型垂体腺瘤
Clin Pract. 2024 Jul 4;14(4):1310-1318. doi: 10.3390/clinpract14040106.
7
Phenotype Transformation of PitNETs.垂体神经内分泌肿瘤的表型转化
Cancers (Basel). 2024 Apr 29;16(9):1731. doi: 10.3390/cancers16091731.
8
Pituitary tumours without distinct lineage differentiation express stem cell marker SOX2.无明显谱系分化的垂体肿瘤表达干细胞标志物 SOX2。
Pituitary. 2024 Jun;27(3):248-258. doi: 10.1007/s11102-024-01385-0. Epub 2024 Mar 14.
9
Pathogenesis, clinical features, and treatment of plurihormonal pituitary adenoma.多激素垂体腺瘤的发病机制、临床特征及治疗
Front Neurosci. 2024 Jan 8;17:1323883. doi: 10.3389/fnins.2023.1323883. eCollection 2023.
10
Single-Cell Transcriptomics Identifies Pituitary Gland Changes in Diet-Induced Obesity in Male Mice.单细胞转录组学鉴定出雄性肥胖症小鼠饮食诱导的垂体变化。
Endocrinology. 2024 Jan 16;165(3). doi: 10.1210/endocr/bqad196.
Endocr Pract. 2018 Jun;24(6):580-588. doi: 10.4158/EP-2018-0084.
4
The 2017 WHO classification of pituitary adenoma: overview and comments.2017 年世界卫生组织垂体腺瘤分类:概述与评论。
Brain Tumor Pathol. 2018 Apr;35(2):51-56. doi: 10.1007/s10014-018-0314-3. Epub 2018 Apr 23.
5
Plurihormonal ACTH-GH Pituitary Adenoma: Case Report and Systematic Literature Review.多激素促肾上腺皮质激素-生长激素垂体腺瘤:病例报告及系统文献综述
World Neurosurg. 2018 Jun;114:e158-e164. doi: 10.1016/j.wneu.2018.02.120. Epub 2018 Mar 6.
6
Immunohistochemical Biomarkers in Pituitary Pathology.垂体病理学中的免疫组化生物标志物。
Endocr Pathol. 2018 Jun;29(2):130-136. doi: 10.1007/s12022-018-9521-z.
7
Epidemiology and biomarker profile of pituitary adenohypophysial tumors.垂体腺垂体肿瘤的流行病学和生物标志物特征。
Mod Pathol. 2018 Jun;31(6):900-909. doi: 10.1038/s41379-018-0016-8. Epub 2018 Feb 12.
8
Thyrotropic pituitary adenoma with plurihormonal immunoreactivity.具有多激素免疫反应性的促甲状腺素垂体腺瘤。
Neurol India. 2017 Sep-Oct;65(5):1162-1164. doi: 10.4103/neuroindia.NI_577_16.
9
Stem/progenitor cells in pituitary organ homeostasis and tumourigenesis.垂体器官稳态与肿瘤发生中的干细胞/祖细胞
J Endocrinol. 2018 Jan;236(1):R1-R13. doi: 10.1530/JOE-17-0258. Epub 2017 Aug 30.
10
Double pituitary adenomas are most commonly associated with GH- and ACTH-secreting tumors: systematic review of the literature.双垂体腺瘤最常与 GH 和 ACTH 分泌性肿瘤相关:文献系统回顾。
Pituitary. 2017 Dec;20(6):702-708. doi: 10.1007/s11102-017-0826-6.